The current status of multimodality treatment for unresectable locally advanced esophageal squamous cell carcinoma
Author:
Affiliation:
1. Gastrointestinal Medical Oncology Division; National Cancer Center Hospital; Tokyo Japan
Publisher
Wiley
Subject
Oncology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajco.12995/fullpdf
Reference36 articles.
1. Global cancer statistics, 2012;Torre;CA: Cancer J Clin,2015
2. Risk factors for esophageal fistula associated with chemoradiotherapy for locally advanced unresectable esophageal cancer: a supplementary analysis of JCOG0303;Tsushima;Medicine,2016
3. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus;Herskovic;N Engl J Med,1992
4. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy;Minsky;J Clin Oncol,2002
5. Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus;Ohtsu;J Clin Oncol,1999
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy and safety of anti-PD-1 antibody plus chemoradiotherapy in locally advanced esophageal squamous cancer;Frontiers in Oncology;2023-02-09
2. HA15 inhibits binding immunoglobulin protein and enhances the efficacy of radiation therapy in esophageal squamous cell carcinoma;Cancer Science;2023-01-11
3. A Review of Hedgehog Signaling in Radioresistant Esophageal Cancer: Potential Treatment Target;Technology in Cancer Research & Treatment;2023-01
4. Correlation between immune‑related adverse events and treatment efficacy of anti‑PD1 immunotherapy in patients with esophageal squamous cell carcinoma;Oncology Letters;2022-12-20
5. Novel nomograms predicting the survival of patients with nonsurgical thoracic esophageal squamous cell carcinoma treated with IMRT: A retrospective analysis;Medicine;2022-10-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3